Veletri and Atrovent drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Veletri (epoprostenol sodium) and Atrovent (ipratropium bromide). Common drug interactions include catheter site pain among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Veletri and Atrovent. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Veletri?

Veletri has active ingredients of epoprostenol sodium. eHealthMe is studying from 14,196 Veletri users. Check the latest studies of Veletri.

What is Atrovent?

Atrovent has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 33,210 Atrovent users. Check the latest studies of Atrovent.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 23, 2026

24 people who take Veletri and Atrovent together, and have interactions are studied.

What are the common drug interactions of Veletri and Atrovent, by gender? *:

female:

Catheter site pain
Catheter site rash
Cellulitis (infection under the skin)
Chronic kidney disease
Chronic right ventricular failure (impaired function of right ventricle of heart)
Cor pulmonale chronic (long lasting enlargement of the right ventricle of the heart)
Cough
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
Dysuria (painful or difficult urination)

male:

Dyspnoea (difficult or laboured respiration)
Brain abscess
Hemiparesis (weakness on one side of the body)
Localised oedema (fluid retention in a particular part of the body)
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Nasal discomfort
Nocardiosis (an infectious disease affecting either the lungs or whole body)
Oedema peripheral (superficial swelling)
Pain in jaw
Palpitations (feelings or sensations that your heart is pounding or racing)

What are the common drug interactions of Veletri and Atrovent, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Pain in extremity
Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)
Asthenia (weakness)
Dizziness
Hot flush (sudden feelings of heat)
Syncope (loss of consciousness with an inability to maintain postural tone)
Catheter site infection (infection at the site of insertion)
Death
Device occlusion
Muscle spasms (muscle contraction)

50-59:

Erythema (redness of the skin)
Application site erosion
Catheter site erythema (redness of skin at catheter site)
Catheter site pruritus (itching at the site)
Constipation
Decreased appetite
Diarrhoea
Eye haemorrhage (bleeding in the eye)
Fatigue (feeling of tiredness)
Flushing (the warm, red condition of human skin)

60+:

Anaemia (lack of blood)
Cardiac failure
Dyspnoea (difficult or laboured respiration)
Flushing (the warm, red condition of human skin)
Neutropenia (an abnormally low number of neutrophils)
Pneumonia
Pulmonary hypertension (increase in blood pressure in the lung artery)
Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)
Respiratory distress (difficulty in breathing)
Respiratory failure (inadequate gas exchange by the respiratory system)

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 13 people, 54.17%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 10 people, 41.67%
Pulmonary Vascular Disorder: 2 people, 8.33%
Primary Myelofibrosis (primary disorder of the bone marrow): 2 people, 8.33%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 8.33%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 2 people, 8.33%
Diabetes: 2 people, 8.33%
Cardiac Failure: 2 people, 8.33%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Veletri and Atrovent?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously